1. The kinetic properties of two genetic variants of human erythrocyte adenylate kinase were studied at limiting concentrations of both ADP and MgADP-in the forward direction and at limiting concentrations of both AMP and MgATP2-in the reverse direction. 2. Primary reciprocal plots rule out the possibility of a Ping Pong mechanism for both forms of the enzyme. 
1. The kinetic properties of two genetic variants of human erythrocyte adenylate kinase were studied at limiting concentrations of both ADP and MgADP-in the forward direction and at limiting concentrations of both AMP and MgATP2-in the reverse direction. 2. Primary reciprocal plots rule out the possibility of a Ping Pong mechanism for both forms of the enzyme. 3. Analysis of the kinetic data by an appropriate computer program gave the following Km values for the type 1 enzyme: AMP, 0.33mM±0.1; MgATP2-, 0.95mM±0.13; ADP, 0.12mM±0.03; 0.22mM±0.04 . Values for the type 2 enzyme were: AMP, 0.27mM±0.03; MgATP2-, 0.40mM±0.05; ADP, 0.08mM±0.07; 0.20mM±0.04. 4 . Product inhibition studies were done by studying the reverse reaction. With ADP as product inhibitor competitive inhibition patterns were obtained with AMP and/or MgATP2-as variable substrate. Similar results were obtained for product inhibition by MgADP-with AMP as variable substrate. The results are consistent with a Rapid Equilibrium Random mechanism. 5. Secondary plots of slope versus product concentration were linear. The data were fitted to the appropriate equation and analysed by computer to give values for the product inhibition constants. 6. Differences between the values of certain kinetic constants for the two forms of the enzyme were observed.
Genetic variation in proteins and enzymes in man appears to fall into two main categories (Harris, 1970) . In the first the gene or genes responsible for variant forms of a protein occur only rarely in the population. These so-called 'rare' variants are often associated with some clinical abnormality in the individual concerned because of the altered properties ofthe variant protein or enzyme. In the second category the gene or genes responsible for alternative form(s) of a particular protein occur with a relatively high frequency (>1 %) so that a considerable proportion of the population possesses the common alternative form(s) of that protein.
The alterations in catalytic properties associated with an enzyme variant are not always obvious and sometimes may only be revealed by detailed kinetic studies. For example, Afolayan & Luzzatto (1971) found significant differences in the product-inhibition and substrate-binding properties of the so-called Avariant of erythrocyte glucose 6-phosphate dehydrogenase, although previous work had suggested that the kinetic properties of this variant and the common form of the enzyme were identical (Kirkman et al., 1960; Marks et aL, 1961) .
It may be argued that when an enzyme variant occurs with a high frequency in the population then the common and alternative form(s) may be expected to have very similar properties, since otherwise natural selection would favour one or other of the forms (Harris, 1959) . This view is supported by the limited evidence available. Scott (1965) measured various kinetic properties of two commonly inherited forms of human erythrocyte acid phosphatase but found no significant difference between them even though the total activity of this enzyme in the erythrocytes of appropriate individuals was markedly different.
We have examined several kinetic parameters of the two common forms of erythrocyte adenylate kinase (Fildes & Harris, 1966 ) by using initialvelocity and product-inhibition studies in a search for possible catalytic differences. These studies were also designed to see whether the human erythrocyte enzyme has a catalytic mechanism similar to that reported for the rabbit muscle (Rhoads & Lowenstein, 1968) and yeast enzymes (Su & Russell, 1968; Khoo & Russell, 1970 (Brownson & Spencer, 1972) 
Methods
Initial-rate measurements. Initial-rate studies, in which the concentrations of the products were considered negligible, were done with coupled assay systems. The reaction 2ADP C ATP+AMP is regarded as the forward reaction and the initial rate was measured by using the coupled assay system described by Brownson & Spencer (1972) and based on the method of Oliver (1955) (DE81) paper by using the ammonium formate buffer, pH 3.1, described by Ives et al. (1963) . Samples (50,u1) of reaction mixtures were co-chromatographed with unlabelled nucleotides as markers. When MgADP-('MgADP') was present as product inhibitor concentrations of MgCl2 up to 50mM were present in the reaction mixtures. Since the additional EDTA necessary to stop the reaction under these conditions interfered with the subsequent chromatographic separation of the labelled nucleotides in these experiments the reaction was terminated by spotting a sample of the reaction mixture directly on to the DEAE-cellulose strip. Chromatograms were irrigated for approx. 4h, dried in the fume cupboard, and the nucleotides detected under a u.v. lamp. Those areas ofthe strips containing nucleotides were cut out (2.5cm x 5cm) and placed in scintillation vials with lOml of toluene solution containing 0.5% (w/v) of 2,5-diphenyloxazole and 0.03% (w/v) of 1,4-bis-(4-methyl-5-phenyloxazol-2-yl)benzene.
The three nucleotides were well resolved on the chromatograms and only insignificant amounts of radioactivity were found in those areas of the strips between the nucleotide spots. Samples were counted for 5 or l0min in a Packard Tri-Carb model 3001 scintillation spectrometer with an efficiency of 80% for 14C and 50% for 3H.
The activities of the adenylate kinase preparations were adjusted by dilution so that reaction rates, measured as c.p.m. of radioactive ADP produced/ min, were linear with time for at least lOmin. Specific radioactivities of the nucleotide substrates were also adjusted by dilution with the appropriate unlabelled nucleotide to give a minimum of 200c.p.m. above background (20c.p.m.) as radioactive ADP, in a 5mi reaction period. Each reaction mixture was run in duplicate and rates were corrected by subtracting zero-time blank values. The rate of reaction is expressed as ,umol of ADP produced/min per ml of undiluted enzyme. This was calculated from the specific radioactivity of the radioactive substrate determined as follows: the concentration of unlabelled nucleotide used for dilution was determined spectrophotometrically and the radioactivity of diluted nucleotides was determined on portions subjected to the chromatographic procedure described above. (Kuby & Noltmann, 1962) and for MgAMP, 1OOM-1 (Nanninga, 1957) . From the values of these constants we have assumed that at the concentrations employed Mg2+ binds preferentially and completely to ATP in the presence of ADP and also that the formation of MgAMP can be neglected in all experiments where the Mg2+ concentration does not exceed the concentration of ATP and/or ADP. The concentrations ofstock MgCI2 solutions were determined by titration against EDTA (Alcock & McIntyre, 1966) .
Analysis. The experimental data, in duplicate, were fitted to one of the two following equations (Cleland, 1963c) (Fig. 3) . However, with AMP as variable substrate the point of intersection was slightly below the abscissa (Fig. 4) results of these experiments again gave a point of intersection below the abscissa.
The families of lines derived with all four substrates are consistent with a sequential mechanism and eliminate the possibility of a Ping Pong mechanism (Cleland, 1963c 
Product-inhibition analysis
Product-inhibition studies were done to determine which of the three possible sequential mechanisms 0.2r best describe the action of the enzyme; the mechanisms are Ordered, Theorell Chance or Random Equilibrium (Cleland, 1963b) . These studies involved measurements of initial rates of reaction in the presence of various concentrations of one substrate with a fixed non-saturating concentration of the second substrate at several different constant concentrations of one product.
With ADP as a product inhibitor of either AMP or MgATP as variable substrate, plots consistent with linear competitive inhibition were obtained (Figs. 5 and 6) . A similar pattern was derived for product inhibition by MgADP with AMP as variable substrate (Fig. 7) . In this experiment the high concentrations of Mg2+ required to complex all the ADP resulted in the formation of significant amounts of MgAMP. The concentrations of uncomplexed AMP shown in Fig. 7 were calculated from the stability constant of MgAMP (see the Experimental section). The enzyme does not appear to be inhibited by high concentrations of MgAMP as the plots in Fig. 7 are linear; similarly no inhibition was observed in initial-velocity studies with ATP and AMP in the presence of high concentrations of Mg2+ (30mM).
In spite of repeated attempts it was not possible to find a suitable concentration of MgADP as product inhibitor that would allow accurate measurements of reaction rates with MgATP as the variable substrate.
The sequential mechanism that fits this productinhibition data best is Rapid Equilibrium Random The following fixed concentrations of MgATP were used: *, 2.13mM; rJ, 1.06mM; o, 0.53mM; *, 0.27mM.
1972 Table 1 . Kinetic constants for adenylate kinase types 1 and 2 Kinetic constants are defined in the text. The constants, ±S.E.M., were calculated from the appropriate initialvelocity data, from experiments with the linked assay systems. hibitor, ADP, was tested at the followir tions: *, no ADP; 0,1.5mM; o, 3.7mM; complex. The complete rate equation for ism is (Cleland, 1963b) Khoo & Russell (1970) for the yeast enzyme. With both the yeast and the muscle enzyme evidence has been produced that AMP acts as an inhibitor under certain conditions. In the case of the yeast enzyme with MgATP as the fixed substrate, high concentrations of the variable substrate (AMP) were inhibitory (Khoo & Russell, 1970 Rhoads & Lowenstein (1968) on the muscle enzyme also gave evidence of substrate inhibition by AMP and it was suggested that the actual inhibitor was MgAMP. In the experiments described here no such inhibition was observed even when the MgAMP concentration was high.
In initial-velocity studies with adenylate kinase types 1 and 2 the patterns of intersecting lines with MgATP as fixed substrate (Fig. 4) indicate that binding of this nucleotide hinders the binding of the variable substrate (AMP) (Westley, 1969 (Koshland, 1958) . Presumably the binding of MgATP induces a conformational change in the enzyme which hinders subsequent binding of AMP whilst the conformation induced by first binding AMP facilitates binding of MgATP.
The validity of the proposed reaction mechanism for the erythrocyte enzymes could not be tested by application of the appropriate Haldane relationships (Haldane, 1930) as the V values obtained were not comparable from one experiment to another because of instability of the enzyme. It was not possible to obtain all four product-inhibition patterns for the reverse reaction as noted previously. For these reasons it would be desirable to further investigate the mechanism by isotope exchange studies.
A limited number of kinetic studies have been done on those erythrocyte enzymes that are known to exist in common alternative forms. The results suggest that any kinetic differences which exist between the various forms of an enzyme are extremely small. Scott (1965) working with acid phosphatase partially purified from erythrocytes of individuals of phenotypes AA and BB (Hopkinson et al., 1963) found no significant differences in Km and V at various pH values. The relative activities of the two enzymes with a variety of substrates were essentially identical. No differences were found between the two enzymes regarding their inhibitor constants for inhibition by inorganic phosphate; Fenton & Richardson (1971) confirmed these findings. Another erythrocyte enzyme that exists in common alternative forms, namely glucose 6-phosphate dehydrogenase, has also been studied in some detail. Binding constants for both NADP+ and NADPH were similar (Afolayan & Luzzatto, 1971) for forms A and B (World Health Organization, 1967) . The present results (Tables 1 and 2) suggest that differences do exist between certain kinetic parameters for the two common forms of erythrocyte adenylate kinase. These differences are not sufficiently clear-cut to warrant a discussion of their possible physiological significance but suggest that further detailed studies may be informative.
